C-ROXIT-250
Powerful Protection Against Bacterial Infections
C-ROXIT 250 Tablets by Citric Labs contain Cefuroxime 250 mg, a broad-spectrum second-generation cephalosporin antibiotic used for the effective treatment of various bacterial infections. It works by stopping the growth of bacteria and helping the body recover faster from infections related to the respiratory tract, urinary tract, skin, throat, ear, and sinus. C-ROXIT 250 is formulated to provide reliable infection control with excellent patient compliance.
Composition
- Cefuroxime Axetil IP equivalent to Cefuroxime – 250 mg
Key Benefits
- Broad-spectrum antibacterial action
- Fast relief from bacterial infections
- Effective against respiratory and urinary infections
- Helps reduce infection-related inflammation and discomfort
- Well-tolerated antibiotic formulation
- Trusted cephalosporin therapy for clinical use
Product Description
C-ROXIT 250 Tablets contain Cefuroxime 250 mg, a broad-spectrum antibiotic used for treating respiratory tract infections, urinary tract infections, throat infections, skin infections, and sinus infections. Manufactured by Citric Labs, it offers effective bacterial infection control with trusted quality and reliable results.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
